The dose of continuous renal replacement therapy for acute renal failure

A systematic review and meta-analysis

Edward T. Casey, Bhanu P. Gupta, Patricia J. Erwin, Victor Manuel Montori, Mohammad H Murad

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: To conduct a systematic review of the literature to summarize the best available evidence regarding the mortality and morbidity associated with differing dosing regimens of continuous renal replacement therapy (CRRT) for patients with acute renal failure (ARF) in an intensive care unit setting. Patients and Methods: We searched for randomized controlled trials in electronic databases from January 1990 through November 2009. Eligible trials compared two or more dosing regimens of CRRT in patients with ARF. Two reviewers working independently determined trial eligibility and extracted descriptive, methodological, and outcome data. Random-effects meta-analysis was used to assess relative risks (RR) and weighted mean difference. The I 2-statistic was used to assess heterogeneity of treatment effect across trials. Results: Seven trials were eligible for meta-analysis. We found no reduction in mortality in patients who received higher doses of CRRT (RR 0.88, 95 CI 0.751.03, I2 74). There was no difference in the requirement of renal replacement therapy at the conclusion of the study period (RR 1.12, 95 CI 0.861.46, I2 3). The overall quality of evidence was downgraded because of imprecision and heterogeneity. Conclusion: Increased dosing of CRRT is not associated with a decrease in mortality of patients with ARF in an intensive care unit setting.

Original languageEnglish (US)
Pages (from-to)555-561
Number of pages7
JournalRenal Failure
Volume32
Issue number5
DOIs
StatePublished - Jun 2010

Fingerprint

Renal Replacement Therapy
Acute Kidney Injury
Meta-Analysis
Intensive Care Units
Mortality
Randomized Controlled Trials
Databases
Morbidity

Keywords

  • Acute renal failure
  • Continuous renal replacement therapy
  • Critical care
  • Hemodiafiltration
  • Hemofiltration
  • Meta-analysis

ASJC Scopus subject areas

  • Nephrology
  • Critical Care and Intensive Care Medicine

Cite this

The dose of continuous renal replacement therapy for acute renal failure : A systematic review and meta-analysis. / Casey, Edward T.; Gupta, Bhanu P.; Erwin, Patricia J.; Montori, Victor Manuel; Murad, Mohammad H.

In: Renal Failure, Vol. 32, No. 5, 06.2010, p. 555-561.

Research output: Contribution to journalArticle

@article{dda33e9482974b9495ac068f5104d3db,
title = "The dose of continuous renal replacement therapy for acute renal failure: A systematic review and meta-analysis",
abstract = "Objectives: To conduct a systematic review of the literature to summarize the best available evidence regarding the mortality and morbidity associated with differing dosing regimens of continuous renal replacement therapy (CRRT) for patients with acute renal failure (ARF) in an intensive care unit setting. Patients and Methods: We searched for randomized controlled trials in electronic databases from January 1990 through November 2009. Eligible trials compared two or more dosing regimens of CRRT in patients with ARF. Two reviewers working independently determined trial eligibility and extracted descriptive, methodological, and outcome data. Random-effects meta-analysis was used to assess relative risks (RR) and weighted mean difference. The I 2-statistic was used to assess heterogeneity of treatment effect across trials. Results: Seven trials were eligible for meta-analysis. We found no reduction in mortality in patients who received higher doses of CRRT (RR 0.88, 95 CI 0.751.03, I2 74). There was no difference in the requirement of renal replacement therapy at the conclusion of the study period (RR 1.12, 95 CI 0.861.46, I2 3). The overall quality of evidence was downgraded because of imprecision and heterogeneity. Conclusion: Increased dosing of CRRT is not associated with a decrease in mortality of patients with ARF in an intensive care unit setting.",
keywords = "Acute renal failure, Continuous renal replacement therapy, Critical care, Hemodiafiltration, Hemofiltration, Meta-analysis",
author = "Casey, {Edward T.} and Gupta, {Bhanu P.} and Erwin, {Patricia J.} and Montori, {Victor Manuel} and Murad, {Mohammad H}",
year = "2010",
month = "6",
doi = "10.3109/08860221003728739",
language = "English (US)",
volume = "32",
pages = "555--561",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The dose of continuous renal replacement therapy for acute renal failure

T2 - A systematic review and meta-analysis

AU - Casey, Edward T.

AU - Gupta, Bhanu P.

AU - Erwin, Patricia J.

AU - Montori, Victor Manuel

AU - Murad, Mohammad H

PY - 2010/6

Y1 - 2010/6

N2 - Objectives: To conduct a systematic review of the literature to summarize the best available evidence regarding the mortality and morbidity associated with differing dosing regimens of continuous renal replacement therapy (CRRT) for patients with acute renal failure (ARF) in an intensive care unit setting. Patients and Methods: We searched for randomized controlled trials in electronic databases from January 1990 through November 2009. Eligible trials compared two or more dosing regimens of CRRT in patients with ARF. Two reviewers working independently determined trial eligibility and extracted descriptive, methodological, and outcome data. Random-effects meta-analysis was used to assess relative risks (RR) and weighted mean difference. The I 2-statistic was used to assess heterogeneity of treatment effect across trials. Results: Seven trials were eligible for meta-analysis. We found no reduction in mortality in patients who received higher doses of CRRT (RR 0.88, 95 CI 0.751.03, I2 74). There was no difference in the requirement of renal replacement therapy at the conclusion of the study period (RR 1.12, 95 CI 0.861.46, I2 3). The overall quality of evidence was downgraded because of imprecision and heterogeneity. Conclusion: Increased dosing of CRRT is not associated with a decrease in mortality of patients with ARF in an intensive care unit setting.

AB - Objectives: To conduct a systematic review of the literature to summarize the best available evidence regarding the mortality and morbidity associated with differing dosing regimens of continuous renal replacement therapy (CRRT) for patients with acute renal failure (ARF) in an intensive care unit setting. Patients and Methods: We searched for randomized controlled trials in electronic databases from January 1990 through November 2009. Eligible trials compared two or more dosing regimens of CRRT in patients with ARF. Two reviewers working independently determined trial eligibility and extracted descriptive, methodological, and outcome data. Random-effects meta-analysis was used to assess relative risks (RR) and weighted mean difference. The I 2-statistic was used to assess heterogeneity of treatment effect across trials. Results: Seven trials were eligible for meta-analysis. We found no reduction in mortality in patients who received higher doses of CRRT (RR 0.88, 95 CI 0.751.03, I2 74). There was no difference in the requirement of renal replacement therapy at the conclusion of the study period (RR 1.12, 95 CI 0.861.46, I2 3). The overall quality of evidence was downgraded because of imprecision and heterogeneity. Conclusion: Increased dosing of CRRT is not associated with a decrease in mortality of patients with ARF in an intensive care unit setting.

KW - Acute renal failure

KW - Continuous renal replacement therapy

KW - Critical care

KW - Hemodiafiltration

KW - Hemofiltration

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=77953011319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953011319&partnerID=8YFLogxK

U2 - 10.3109/08860221003728739

DO - 10.3109/08860221003728739

M3 - Article

VL - 32

SP - 555

EP - 561

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 5

ER -